Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Page

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Dalton Transactions (Cambridge, England : 2003)|November 13, 2008
Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's diseaseLauren E Scott, Brent D G Page, Brian O Patrick, et al.
Drug and Chemical Toxicology|January 1, 1983
Subchronic toxicology of diethystilbestrol in the mouseD W Barnes, D G Page, S S Duke, et al.
ACS Chemical Biology|May 16, 2020
Validating Signal Transducer and Activator of Transcription (STAT) Protein-Inhibitor Interactions Using Biochemical and Cellular Thermal Shift AssaysSanaz Attarha, Anja Reithmeier, Sander Busker, et al.
ACS Omega|April 8, 2020
Homology Modeling of Human Uridine-5'-diphosphate-glucuronosyltransferase 1A6 Reveals Insights into Factors Influencing Substrate and Cosubstrate BindingAlexander D Smith, Brent D G Page, Abby C Collier, et al.
Virginia Dental Journal|January 1, 1996
Needlesticks: what to do after it happensG E Kaugars, D G Page, L M Abbey, et al.
Oral Surgery, Oral Medicine, and Oral Pathology|September 1, 1994
Comparison of articles published in Oral Surgery Oral Medicine Oral Pathology in 1972 and 1992G E Kaugars, W T Riley, T M Grisius, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|November 26, 2009
Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) proteinSteven Fletcher, Joel A Drewry, Vijay M Shahani, et al.
Journal of Oral Medicine|January 1, 1985
Racial predilection of ameloblastoma? A probable answer from Lagos (Nigeria) and Richmond, Virginia (U.S.A.)D R Sawyer, A Mosadomi, D G Page, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|April 2, 1999
Oral verrucous carcinomaG E Kaugars, L M Abbey, J C Burns, et al.
Expert Opinion on Therapeutic Patents|May 24, 2024
Type II & III inhibitors of tropomyosin receptor kinase (Trk): a 2020-2022 patent updatePetar Iliev, Carolin Jaworski, Carmen Wängler, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Dalton Transactions (Cambridge, England : 2003)|November 13, 2008
Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's diseaseLauren E Scott, Brent D G Page, Brian O Patrick, et al.
Drug and Chemical Toxicology|January 1, 1983
Subchronic toxicology of diethystilbestrol in the mouseD W Barnes, D G Page, S S Duke, et al.
ACS Chemical Biology|May 16, 2020
Validating Signal Transducer and Activator of Transcription (STAT) Protein-Inhibitor Interactions Using Biochemical and Cellular Thermal Shift AssaysSanaz Attarha, Anja Reithmeier, Sander Busker, et al.
ACS Omega|April 8, 2020
Homology Modeling of Human Uridine-5'-diphosphate-glucuronosyltransferase 1A6 Reveals Insights into Factors Influencing Substrate and Cosubstrate BindingAlexander D Smith, Brent D G Page, Abby C Collier, et al.
Virginia Dental Journal|January 1, 1996
Needlesticks: what to do after it happensG E Kaugars, D G Page, L M Abbey, et al.
Oral Surgery, Oral Medicine, and Oral Pathology|September 1, 1994
Comparison of articles published in Oral Surgery Oral Medicine Oral Pathology in 1972 and 1992G E Kaugars, W T Riley, T M Grisius, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|November 26, 2009
Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) proteinSteven Fletcher, Joel A Drewry, Vijay M Shahani, et al.
Journal of Oral Medicine|January 1, 1985
Racial predilection of ameloblastoma? A probable answer from Lagos (Nigeria) and Richmond, Virginia (U.S.A.)D R Sawyer, A Mosadomi, D G Page, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|April 2, 1999
Oral verrucous carcinomaG E Kaugars, L M Abbey, J C Burns, et al.
Expert Opinion on Therapeutic Patents|May 24, 2024
Type II & III inhibitors of tropomyosin receptor kinase (Trk): a 2020-2022 patent updatePetar Iliev, Carolin Jaworski, Carmen Wängler, et al.
Pageof 8